NextCure Inc. (NXTC) PT Lowered to $6 at Piper Sandler
Tweet
Share
E-mailGet Alerts NXTC Hot Sheet
Price: $6.26 +7.38%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 6 | New: 11
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 6 | New: 11
Join SI Premium – FREE
Piper Sandler analyst Edward Tenthoff lowered the price target on NextCure Inc. (NASDAQ: NXTC) to $6.00 (from $13.00) while maintaining a rating.
You May Also Be Interested In
- Okta, Inc (OKTA) PT Raised to $143 at Bernstein SocGen Group
- Schott Pharma AG (1SXP:GR) PT Raised to EUR25.70 at Stifel
- China Overseas Land & Investment Ltd. (688:HK) (CAOVF) PT Raised to HK$16.80 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
